EjectDelay’s active ingredient is a fast absorbing and vanishing gel formulation with the active drug benzocaine at 7.5% designed to reduce transfer to the partner. A total of
About 375 patients with type 2 diabetes are expected to be enrolled in the trial, which will be performed by the company’s development partner, Eli Lilly and Company.
The Phase I/II oncology trial is designed to assess the efficacy and safety of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte’s oral indoleamine dioxygenase-1
The new global CoLaborator concept is aimed at providing young companies in the area of chemistry and biosciences ready-to-use laboratory and office infrastructure in the immediate vicinity of
The deal includes an option to acquire the technology during clinical development. Along with the June 2013 acquisition of Synacthen, the new deal expands the company’s portfolio of
The research deal will target the development of new products that use the proprietary Ligand-developed LTP TECHNOLOGY to improve lipid-lowering activity of certain omega-3 fatty acids. Ligand president
The trial is a Phase I, open label, dose escalation study of immunoconjugate L-DOS47 in combination with vinorelbine in patients with metastatic or advanced solid tumors. Helix president
The deal will allow Novozymes to provide the pharma industry serum stable albumin drug conjugates with improved pharmacokinetic and/or targeting capabilities. Under the deal, Novozymes’ customers will be
Currently, Zestra is approved and marketed in Canada for the indication of ‘Temporary Increase of Desire in Female Sexual Desire Disorder Women (FSDD)’. The company said that the
Based on the company’s Localized Drug Action platform, AMA0076 is a highly potent locally-acting Rho Kinase (ROCK) inhibitor designed to reduce intraocular pressure (IOP) by acting specifically on
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.